Study on the clinical efficacy of specific phosphodiesterase inhibitor in patients with pulmonary hypertension due to left heart disease

Pulmonary hypertension due to left heart disease (PH-LHD) is caused by left ventricular (LV) systolic and/or diastolic dysfunction and left heart valve disease. LV diseases lead to left ventricular filling pressure increases, pulmonary venous obstruction and pulmonary venous pressure increases, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Bing, Wang, Qingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090457/
https://www.ncbi.nlm.nih.gov/pubmed/30112056
http://dx.doi.org/10.3892/etm.2018.6310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090457/
https://www.ncbi.nlm.nih.gov/pubmed/30112056
http://dx.doi.org/10.3892/etm.2018.6310

Ejemplares similares